** Shares in DSM-Firmenich DSFIR.AS fall 5.5% after the chemicals group agreed to sell its Animal Nutrition & Health business to CVC Capital CVC.AS for an EV of around EUR 2.2 bln ($2.61 bln)
** KBC Securities says the deal value was below its consensus of EUR 3 bln, adding other elements like the EUR 500 million earn-out and the provision of a loan and liquidity facility prove disappointing
** ING also sees the details as disappointing" with the below-expectations value and a "sizeable impairment" of EUR 1.9 bln before taxes in 2025
** ING is, however, "glad" the company can finally move forward
** Shares will see their worst day since early-April if losses persist
($1 = 0.8432 euros)
(Reporting by Jakob Van Calster)
((jakob.vancalster@thomsonreuters.com))